![](/img/cover-not-exists.png)
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study
Roger J Laham, Nicholas A Chronos, Marilyn Pike, Mark E Leimbach, James E Udelson, Justin D Pearlman, Roderic I Pettigrew, M.J Whitehouse, Carl Yoshizawa, Michael SimonsVolume:
36
Year:
2000
Language:
english
DOI:
10.1016/s0735-1097(00)00988-8
File:
PDF, 339 KB
english, 2000